The Peter A. Singer Thyroid Symposium 2024

Saturday, May 18, 2024, 7:00 AM - 2:30 PM, Aresty Conference Center - USC Health Sciences Campus, Los Angeles, CA

AMA PRA Category 1 Credits™ (5.50 hours), Non-Physician Attendance (5.50 hours)

The USC Peter A. Singer Thyroid Symposium returns for 2024, continuing our dedication to providing a comprehensive and current update in the management of thyroid disease. This will again be a hybrid program, offering options for in-person or virtual attendance. Clinical care of patients with thyroid disorders continues to change and develop in complexity. 
In our 2024 edition, the following is highlighted: disparities in thyroid cancer care along with key areas for specialists and general providers alike: treatment of Graves' disease, additional use of T3 medication, health practices for Hashimoto's disease, evaluation of thyroid nodules, disparities in thyroid cancer care, active surveillance of thyroid cancer and management of lymph node recurrences, and thyroid disease in pregnancy. 
Forward-looking perspectives are presented on the most current state of thyroid medicine informed by evidenced-based management strategies, with sessions combining clinical experience, challenging cases, panel discussions, and audience questions to inform solutions to complex clinical scenarios. 

1. • Provide optimal patient counseling and consideration for active surveillance for low-risk papillary thyroid cancer.
2. • Examine new evidence of T4 and T3 combination therapy for hypothyroidism and in what patients it might be used.
3. • Distinguish advantages and disadvantaged between primary treatments for Graves’ Disease.
4. • Recognize areas of healthcare disparity in thyroid cancer care.
5. • Assess effectiveness of non-pharmaceutical and lifestyle measures of Hashimoto thyroiditis.
6. • Decide optimal timing and interventions for thyroid cancer lymph node metastases.
7. • Identify ultrasound findings that impact cancer risk for indeterminate thyroid nodules.
8. • Review current practice considerations for management of thyroid disease as it pertains to fertility.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 5.50 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Cancellation Policy
Cancellations must be received by the USC Office of CME by email only by May 14, 2024 by 12:00 pm PDT for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].

The Keck School of Medicine Healthcare System School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Keck School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Saturday, May 18, 2024